Journal article icon

Journal article

Inhibition of a viral prolyl hydroxylase

Abstract:
The hydroxylation of prolyl-residues in eukaryotes is important in collagen biosynthesis and in hypoxic signalling. The hypoxia inducible factor (HIF) prolyl hydroxylases (PHDs) are drug targets for the treatment of anaemia, while the procollagen prolyl hydroxylases and other 2-oxoglutarate dependent oxygenases are potential therapeutic targets for treatment of cancer, fibrotic disease, and infection. We describe assay development and inhibition studies for a procollagen prolyl hydroxylase from Paramecium bursaria chlorella virus 1 (vCPH). The results reveal HIF PHD inhibitors in clinical trials also inhibit vCPH. Implications for the targeting of the human PHDs and microbial prolyl hydroxylases are discussed.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.bmc.2019.01.018

Authors


More by this author
Role:
Author
ORCID:
0000-0003-0875-3712
More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Chemistry
Sub department:
Organic Chemistry
Role:
Author
ORCID:
0000-0003-2141-5988
More by this author
Institution:
University of Oxford
Department:
Chemistry
Sub department:
Organic Chemistry
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Chemistry
Sub department:
Organic Chemistry
Role:
Author
ORCID:
0000-0002-0290-6565


Publisher:
Elsevier
Journal:
Bioorganic and Medicinal Chemistry More from this journal
Volume:
27
Issue:
12
Pages:
2405-2412
Publication date:
2019-01-23
Acceptance date:
2019-01-21
DOI:
EISSN:
1464-3391
ISSN:
0968-0896
Pmid:
30737136


Language:
English
Keywords:
Pubs id:
pubs:972927
UUID:
uuid:8838de20-f9f2-4954-9a8a-1bcb7d423d27
Local pid:
pubs:972927
Source identifiers:
972927
Deposit date:
2019-03-12

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP